PTAB challenges

Proceedings overview

There is one AIA trial proceeding on file for US patent 9734825. This proceeding, IPR2025-01336, resulted in a denial of institution, leaving all challenged claims of the patent intact. This outcome provides a strong defensive posture for the patent owner, as the patent has survived an IPR challenge at the institution stage.

IPR2025-01336 — Meta Platforms, Inc. v. Dialect, LLC

• Type: Inter Partes Review
• Filed: 2025-08-15
• Status: Institution Denied — The Patent Trial and Appeal Board (PTAB) declined to institute a trial in this proceeding.
• Judge panel: The institution decision was issued by Director John A. Squires, likely in consultation with PTAB judges, as per the USPTO's interim process for institution decisions in effect at the time. Specific names of consulting judges are not publicly available in the search results for this case.
• Petition grounds: Meta Platforms, Inc. (Petitioner) challenged claims 5-8 of US9734825. The petition relied on prior art including U.S. Patent No. 7,085,723 (Ross et al.), WO 00/11571 (Hartono et al.), U.S. Patent No. 5,937,383 (Ittycheriah et al.), U.S. Patent No. 6,636,848 (Aridor et al.), U.S. Patent Application Publication No. 2002/1065860 (Glover et al.), U.S. Patent No. 7,127,402 (Ross et al.), U.S. Patent No. 5,680,511 (Baker et al.), and U.S. Patent No. 7,249,018 (Ross et al.). The Patent Owner's Preliminary Response specifically highlighted arguments related to the Petitioner's interpretation of "agent" and "parser" in claim 5.
• Institution decision: Denied on 2026-02-09. The decision for denial was preceded by a "Director Discretionary Decision: Refer" on 2025-12-10. This timeframe aligns with the USPTO Director John A. Squires's policy shifts, which, from October 2025, involved the Director personally determining institution, often with a focus on discretionary denial grounds, including considerations like inconsistent claim construction positions raised in parallel litigation. While the exact reasoning for denial in IPR2025-01336 is not detailed in the provided snippets, the Patent Owner's Preliminary Response argued against the Petitioner's claim construction of terms such as "agent" and "parser" in claim 5, suggesting potential grounds for the denial related to the adequacy of the petition's arguments or alignment with the Director's discretion.
• Final Written Decision: Not applicable, as institution was denied.
• Settlement / termination: Not applicable, as institution was denied.
• Appeal: Not applicable, as institution was denied.
• Defensive value: The denial of institution for IPR2025-01336 means that claims 5-8 of US9734825 successfully withstood a challenge at the PTAB. For a defendant facing assertion of this patent today, this proceeding indicates that these claims have a degree of resilience against prior art arguments similar to those presented by Meta Platforms. An IPR-based defense using substantially the same grounds and arguments as those raised in IPR2025-01336 would likely face similar challenges, potentially making an IPR-based defense harder for the same or privy parties.

Strategic summary

Currently, claims 5-8 of US9734825 have been SUSTAINED in the context of PTAB proceedings, as institution was denied for IPR2025-01336. All other claims (1-4, 9-20) remain UNTESTED by any AIA trial proceeding mentioned in this analysis. The patent has not been narrowed through IPR, maintaining its full scope.

Regarding the estoppel landscape, 35 U.S.C. § 315(e)(2) prevents Meta Platforms, Inc., and any parties in privity with them, from raising any ground that was raised or reasonably could have been raised in IPR2025-01336 concerning claims 5-8. For other potential defendants, the prior art grounds (U.S. Patent No. 7,085,723, WO 00/11571, U.S. Patent No. 5,937,383, etc.) used against claims 5-8 are technically still available, but the institution denial decision provides insight into the PTAB's likely stance on similar arguments, especially concerning claim construction. The Director's enhanced discretionary authority at the time of denial also signals that petitions must be robustly argued and avoid inconsistent positions with parallel litigation.

A key pattern signal here is the institution denial by Director John A. Squires, which reflects a broader policy shift at the USPTO beginning in late 2025 to curtail access to IPRs, particularly when petitions lack sufficient justification for claim construction inconsistencies or fail other discretionary factors. This suggests that future IPR petitions targeting this patent, or others, will face a stricter institutional bar, making successful institution more challenging. Dialect, LLC, as the patent owner, successfully defended its claims at this initial stage.

Recommended next steps

For a defendant considering challenging US patent 9734825, the primary consideration is the institution denial of IPR2025-01336. This indicates that claims 5-8 are currently robust against the specific prior art and arguments presented in that petition.

• Review the Institution Decision: It is crucial to obtain and thoroughly review the full institution decision for IPR2025-01336, particularly the panel's reasoning for denying institution. This decision (Paper 15 in the IPR2025-01336 docket, dated 2026-02-09) would clarify the specific deficiencies identified in Meta's petition. While a direct link to the USPTO PTAB E2E system is not available here, this document can be accessed via the USPTO's Patent Trial and Appeal Board End-to-End (PTAB E2E) system by searching for IPR2025-01336.
• Analyze Challenged Claims and Prior Art: Understand exactly why claims 5-8 were not instituted as unpatentable. Focus on the PTAB's interpretation of key claim terms (e.g., "agent," "parser") and how they distinguished the claims from the cited prior art (Ross, Ittycheriah, etc.).
• Evaluate New Grounds/Art: If considering a new IPR, a defendant must develop significantly different and stronger grounds of unpatentability, or introduce new and highly relevant prior art that was not "reasonably could have been raised" in IPR2025-01336. Given the Director's active role in institution decisions since late 2025, careful attention to avoiding any claim construction inconsistencies with parallel litigation is paramount.
• Focus on Untested Claims: Claims 1-4 and 9-20 have not been subject to PTAB review. These claims might present a more viable target for a new IPR, assuming strong prior art can be identified.
• Monitor Litigation: Keep abreast of any ongoing district court litigation involving Dialect, LLC and US9734825, especially those involving Meta Platforms, Inc. (e.g., Dialect, LLC v. Meta Platforms, Inc., Civ. No. 7:25-cv-60 (W.D. Tex.)), as the outcomes or settlement terms could impact the patent's value and strategic options.